T&L Co., Ltd. (KOSDAQ:340570)

South Korea · Delayed Price · Currency is KRW

54,700

-300 (-0.55%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Medical Products	174.89B	115.46B	81.58B	71.90B	40.63B
Medical Products Growth	51.47%	41.54%	13.47%	76.94%	24.56%
Total	174.89B	115.46B	81.58B	71.90B	40.63B
Total Growth	51.47%	41.54%	13.47%	76.94%	24.56%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
South Korea	40.86B	35.03B	32.35B	29.11B	24.64B
South Korea Growth	16.64%	8.29%	11.14%	18.12%	8.63%
United States of America	103.33B	63.94B	38.63B	30.83B	7.85B
United States of America Growth	61.61%	65.53%	25.30%	292.54%	196.79%
Others	30.70B	16.49B	10.60B	11.96B	8.14B
Others Growth	86.18%	55.55%	-11.38%	46.99%	11.61%
Total	174.89B	115.46B	81.58B	71.90B	40.63B
Total Growth	51.47%	41.54%	13.47%	76.94%	24.56%

Source: S&P Global Market Intelligence.